Solara Active Pharma Sciences Limited (BOM:541540)
India
· Delayed Price · Currency is INR 481.50
-0.50 (-0.10%)
At close: May 29, 2025
BOM:541540 Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 28, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2020 |
| Market Capitalization | 23,174 | 24,661 | 13,353 | 11,787 | 23,977 | 50,056 | Upgrade
|
| Market Cap Growth | 84.69% | 84.69% | 13.28% | -50.84% | -52.10% | 319.28% | Upgrade
|
| Enterprise Value | 31,120 | 33,026 | 23,165 | 21,509 | 31,550 | 53,179 | Upgrade
|
| Last Close Price | 481.50 | 512.70 | 343.26 | 302.67 | 613.03 | 1282.75 | Upgrade
|
| PE Ratio | 4291.42 | 4566.82 | - | - | - | 22.61 | Upgrade
|
| PS Ratio | 1.81 | 1.92 | 1.04 | 0.82 | 1.89 | 3.10 | Upgrade
|
| PB Ratio | 2.11 | 2.25 | 1.43 | 0.79 | 1.57 | 3.14 | Upgrade
|
| P/TBV Ratio | 3.31 | 3.53 | 2.54 | 1.09 | 2.20 | 4.38 | Upgrade
|
| P/FCF Ratio | 13.40 | 14.27 | 19.69 | 26.23 | - | - | Upgrade
|
| P/OCF Ratio | 10.89 | 11.59 | 12.27 | 7.54 | - | 32.20 | Upgrade
|
| EV/Sales Ratio | 2.42 | 2.57 | 1.80 | 1.49 | 2.49 | 3.29 | Upgrade
|
| EV/EBITDA Ratio | 15.09 | 16.01 | - | 16.36 | 39.77 | 13.73 | Upgrade
|
| EV/EBIT Ratio | 29.08 | 30.86 | - | 77.96 | - | 18.68 | Upgrade
|
| EV/FCF Ratio | 18.00 | 19.10 | 34.16 | 47.86 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.73 | 0.73 | 1.00 | 0.67 | 0.68 | 0.39 | Upgrade
|
| Debt / EBITDA Ratio | 3.86 | 3.86 | - | 7.55 | 12.63 | 1.59 | Upgrade
|
| Debt / FCF Ratio | 4.61 | 4.61 | 13.84 | 22.54 | - | - | Upgrade
|
| Asset Turnover | 0.56 | 0.56 | 0.49 | 0.49 | 0.46 | 0.68 | Upgrade
|
| Inventory Turnover | 1.85 | 1.85 | 1.88 | 1.48 | 1.63 | 2.68 | Upgrade
|
| Quick Ratio | 0.36 | 0.36 | 0.33 | 0.53 | 0.56 | 0.94 | Upgrade
|
| Current Ratio | 0.77 | 0.77 | 0.64 | 1.08 | 1.17 | 1.34 | Upgrade
|
| Return on Equity (ROE) | 0.05% | 0.05% | -46.49% | -1.47% | -3.74% | 16.50% | Upgrade
|
| Return on Assets (ROA) | 2.92% | 2.92% | -4.70% | 0.59% | -0.58% | 7.46% | Upgrade
|
| Return on Capital (ROIC) | 3.55% | 3.55% | -5.62% | 0.68% | -0.68% | 8.84% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.30% | 8.30% | - | 1.50% | - | 15.60% | Upgrade
|
| Earnings Yield | 0.02% | 0.02% | -42.49% | -1.88% | -2.43% | 4.42% | Upgrade
|
| FCF Yield | 7.46% | 7.01% | 5.08% | 3.81% | -18.80% | -0.38% | Upgrade
|
| Dividend Yield | - | - | - | - | - | 0.55% | Upgrade
|
| Payout Ratio | - | - | - | - | - | 8.91% | Upgrade
|
| Buyback Yield / Dilution | -7.15% | -7.15% | 0.00% | -0.15% | -4.75% | -28.19% | Upgrade
|
| Total Shareholder Return | - | -7.15% | - | -0.15% | -4.75% | -27.64% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.